Chemed (NYSE:CHE) Releases Earnings Results, Misses Expectations By $0.12 EPS

Chemed (NYSE:CHE) released its earnings results on Tuesday. The company reported $5.64 earnings per share (EPS) for the quarter, missing the consensus estimate of $5.76 by ($0.12), Briefing.com reports. The company had revenue of $606.18 million for the quarter, compared to analyst estimates of $612.22 million. Chemed had a return on equity of 27.86% and a net margin of 12.69%. The business’s revenue for the quarter was up 7.4% compared to the same quarter last year. During the same period last year, the company posted $5.32 earnings per share. Chemed updated its FY24 guidance to $23.00-$23.15 EPS and its FY 2024 guidance to 23.000-23.150 EPS.

Chemed Trading Down 1.1 %

CHE stock traded down $5.69 during mid-day trading on Friday, hitting $534.55. The stock had a trading volume of 124,456 shares, compared to its average volume of 84,849. The firm has a fifty day simple moving average of $586.09 and a 200 day simple moving average of $568.84. The firm has a market capitalization of $8.04 billion, a P/E ratio of 27.32, a P/E/G ratio of 2.18 and a beta of 0.44. Chemed has a 52 week low of $525.36 and a 52 week high of $654.62.

Insider Transactions at Chemed

In related news, Director Andrea R. Lindell sold 831 shares of Chemed stock in a transaction that occurred on Friday, August 16th. The shares were sold at an average price of $571.51, for a total value of $474,924.81. Following the transaction, the director now directly owns 5,725 shares of the company’s stock, valued at $3,271,894.75. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. In other Chemed news, Director Andrea R. Lindell sold 831 shares of the firm’s stock in a transaction on Friday, August 16th. The stock was sold at an average price of $571.51, for a total value of $474,924.81. Following the sale, the director now owns 5,725 shares of the company’s stock, valued at approximately $3,271,894.75. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CEO Kevin J. Mcnamara sold 2,000 shares of the business’s stock in a transaction on Monday, August 5th. The stock was sold at an average price of $569.63, for a total value of $1,139,260.00. Following the transaction, the chief executive officer now directly owns 105,735 shares of the company’s stock, valued at $60,229,828.05. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 7,144 shares of company stock valued at $4,141,679. Company insiders own 3.32% of the company’s stock.

About Chemed

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.